nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitisinone—HPD—gonad—testicular cancer	0.0897	0.581	CbGeAlD
Nitisinone—HPD—testis—testicular cancer	0.0647	0.419	CbGeAlD
Nitisinone—Septicemia—Etoposide—testicular cancer	0.0331	0.0391	CcSEcCtD
Nitisinone—Septicemia—Methotrexate—testicular cancer	0.0198	0.0234	CcSEcCtD
Nitisinone—Septicemia—Epirubicin—testicular cancer	0.0185	0.0219	CcSEcCtD
Nitisinone—Septicemia—Doxorubicin—testicular cancer	0.0172	0.0203	CcSEcCtD
Nitisinone—Neoplasm malignant—Chlorambucil—testicular cancer	0.0168	0.0199	CcSEcCtD
Nitisinone—Amenorrhoea—Chlorambucil—testicular cancer	0.0164	0.0193	CcSEcCtD
Nitisinone—Hepatomegaly—Dactinomycin—testicular cancer	0.0147	0.0173	CcSEcCtD
Nitisinone—Photophobia—Vinblastine—testicular cancer	0.0124	0.0146	CcSEcCtD
Nitisinone—Neoplasm malignant—Ifosfamide—testicular cancer	0.0111	0.0132	CcSEcCtD
Nitisinone—Amenorrhoea—Ifosfamide—testicular cancer	0.0108	0.0128	CcSEcCtD
Nitisinone—Cyanosis—Etoposide—testicular cancer	0.0106	0.0125	CcSEcCtD
Nitisinone—Infection—Carboplatin—testicular cancer	0.0099	0.0117	CcSEcCtD
Nitisinone—Respiratory failure—Ifosfamide—testicular cancer	0.00968	0.0114	CcSEcCtD
Nitisinone—Sepsis—Dactinomycin—testicular cancer	0.009	0.0106	CcSEcCtD
Nitisinone—Hepatic failure—Dactinomycin—testicular cancer	0.00838	0.00991	CcSEcCtD
Nitisinone—Sepsis—Ifosfamide—testicular cancer	0.00825	0.00976	CcSEcCtD
Nitisinone—Hepatic function abnormal—Ifosfamide—testicular cancer	0.0079	0.00934	CcSEcCtD
Nitisinone—Hepatic failure—Ifosfamide—testicular cancer	0.00768	0.00908	CcSEcCtD
Nitisinone—Encephalopathy—Methotrexate—testicular cancer	0.00701	0.00829	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Ifosfamide—testicular cancer	0.0069	0.00816	CcSEcCtD
Nitisinone—Agranulocytosis—Vinblastine—testicular cancer	0.00688	0.00813	CcSEcCtD
Nitisinone—Rash maculo-papular—Etoposide—testicular cancer	0.00682	0.00807	CcSEcCtD
Nitisinone—Haemoglobin—Vinblastine—testicular cancer	0.00665	0.00786	CcSEcCtD
Nitisinone—Haemorrhage—Vinblastine—testicular cancer	0.00661	0.00782	CcSEcCtD
Nitisinone—Sepsis—Etoposide—testicular cancer	0.00652	0.00771	CcSEcCtD
Nitisinone—Keratitis—Epirubicin—testicular cancer	0.00649	0.00767	CcSEcCtD
Nitisinone—Alopecia—Chlorambucil—testicular cancer	0.00638	0.00754	CcSEcCtD
Nitisinone—Cyanosis—Methotrexate—testicular cancer	0.00635	0.00751	CcSEcCtD
Nitisinone—Keratitis—Doxorubicin—testicular cancer	0.006	0.0071	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Cisplatin—testicular cancer	0.00595	0.00704	CcSEcCtD
Nitisinone—Hepatomegaly—Epirubicin—testicular cancer	0.00595	0.00703	CcSEcCtD
Nitisinone—Alopecia—Vinblastine—testicular cancer	0.00584	0.00691	CcSEcCtD
Nitisinone—Agitation—Chlorambucil—testicular cancer	0.00577	0.00683	CcSEcCtD
Nitisinone—Leukopenia—Chlorambucil—testicular cancer	0.00562	0.00665	CcSEcCtD
Nitisinone—Haemoglobin—Bleomycin—testicular cancer	0.00561	0.00664	CcSEcCtD
Nitisinone—Haemorrhage—Bleomycin—testicular cancer	0.00559	0.00661	CcSEcCtD
Nitisinone—Dehydration—Cisplatin—testicular cancer	0.00553	0.00654	CcSEcCtD
Nitisinone—Hepatomegaly—Doxorubicin—testicular cancer	0.0055	0.00651	CcSEcCtD
Nitisinone—Rash erythematous—Epirubicin—testicular cancer	0.0055	0.0065	CcSEcCtD
Nitisinone—Convulsion—Chlorambucil—testicular cancer	0.00544	0.00644	CcSEcCtD
Nitisinone—Agranulocytosis—Dactinomycin—testicular cancer	0.00542	0.00641	CcSEcCtD
Nitisinone—Conjunctivitis—Ifosfamide—testicular cancer	0.00517	0.00611	CcSEcCtD
Nitisinone—Leukopenia—Vinblastine—testicular cancer	0.00515	0.0061	CcSEcCtD
Nitisinone—Infection—Chlorambucil—testicular cancer	0.00509	0.00602	CcSEcCtD
Nitisinone—Rash erythematous—Doxorubicin—testicular cancer	0.00509	0.00601	CcSEcCtD
Nitisinone—Thrombocytopenia—Chlorambucil—testicular cancer	0.00502	0.00594	CcSEcCtD
Nitisinone—Convulsion—Vinblastine—testicular cancer	0.00499	0.0059	CcSEcCtD
Nitisinone—Agranulocytosis—Ifosfamide—testicular cancer	0.00496	0.00587	CcSEcCtD
Nitisinone—Alopecia—Bleomycin—testicular cancer	0.00494	0.00584	CcSEcCtD
Nitisinone—Neoplasm malignant—Epirubicin—testicular cancer	0.00493	0.00583	CcSEcCtD
Nitisinone—Haemoglobin—Ifosfamide—testicular cancer	0.0048	0.00567	CcSEcCtD
Nitisinone—Amenorrhoea—Epirubicin—testicular cancer	0.00479	0.00567	CcSEcCtD
Nitisinone—Haemorrhage—Ifosfamide—testicular cancer	0.00477	0.00565	CcSEcCtD
Nitisinone—Alopecia—Dactinomycin—testicular cancer	0.0046	0.00544	CcSEcCtD
Nitisinone—Thrombocytopenia—Vinblastine—testicular cancer	0.0046	0.00544	CcSEcCtD
Nitisinone—Respiratory failure—Methotrexate—testicular cancer	0.00458	0.00542	CcSEcCtD
Nitisinone—Neoplasm malignant—Doxorubicin—testicular cancer	0.00456	0.00539	CcSEcCtD
Nitisinone—Eye disorder—Ifosfamide—testicular cancer	0.00446	0.00528	CcSEcCtD
Nitisinone—Conjunctivitis—Cisplatin—testicular cancer	0.00446	0.00527	CcSEcCtD
Nitisinone—Amenorrhoea—Doxorubicin—testicular cancer	0.00443	0.00524	CcSEcCtD
Nitisinone—Melaena—Methotrexate—testicular cancer	0.00439	0.0052	CcSEcCtD
Nitisinone—Leukopenia—Bleomycin—testicular cancer	0.00435	0.00515	CcSEcCtD
Nitisinone—Alopecia—Ifosfamide—testicular cancer	0.00422	0.00499	CcSEcCtD
Nitisinone—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00419	0.00496	CcSEcCtD
Nitisinone—Melaena—Epirubicin—testicular cancer	0.00411	0.00486	CcSEcCtD
Nitisinone—Leukopenia—Dactinomycin—testicular cancer	0.00406	0.0048	CcSEcCtD
Nitisinone—Abdominal pain—Chlorambucil—testicular cancer	0.00405	0.00479	CcSEcCtD
Nitisinone—Infection—Bleomycin—testicular cancer	0.00394	0.00466	CcSEcCtD
Nitisinone—Agranulocytosis—Etoposide—testicular cancer	0.00392	0.00464	CcSEcCtD
Nitisinone—Sepsis—Methotrexate—testicular cancer	0.0039	0.00462	CcSEcCtD
Nitisinone—Thrombocytopenia—Bleomycin—testicular cancer	0.00389	0.0046	CcSEcCtD
Nitisinone—Eye disorder—Cisplatin—testicular cancer	0.00385	0.00455	CcSEcCtD
Nitisinone—Gastrointestinal pain—Vinblastine—testicular cancer	0.00384	0.00454	CcSEcCtD
Nitisinone—Rash maculo-papular—Epirubicin—testicular cancer	0.00383	0.00452	CcSEcCtD
Nitisinone—Agitation—Ifosfamide—testicular cancer	0.00382	0.00452	CcSEcCtD
Nitisinone—Melaena—Doxorubicin—testicular cancer	0.0038	0.0045	CcSEcCtD
Nitisinone—Leukopenia—Ifosfamide—testicular cancer	0.00372	0.0044	CcSEcCtD
Nitisinone—Abdominal pain—Vinblastine—testicular cancer	0.00371	0.00439	CcSEcCtD
Nitisinone—Infection—Dactinomycin—testicular cancer	0.00368	0.00435	CcSEcCtD
Nitisinone—Sepsis—Epirubicin—testicular cancer	0.00365	0.00432	CcSEcCtD
Nitisinone—Alopecia—Cisplatin—testicular cancer	0.00364	0.0043	CcSEcCtD
Nitisinone—Hepatic failure—Methotrexate—testicular cancer	0.00363	0.0043	CcSEcCtD
Nitisinone—Pruritus—Chlorambucil—testicular cancer	0.00363	0.00429	CcSEcCtD
Nitisinone—Thrombocytopenia—Dactinomycin—testicular cancer	0.00362	0.00429	CcSEcCtD
Nitisinone—Convulsion—Ifosfamide—testicular cancer	0.0036	0.00426	CcSEcCtD
Nitisinone—Rash maculo-papular—Doxorubicin—testicular cancer	0.00354	0.00419	CcSEcCtD
Nitisinone—Eye disorder—Etoposide—testicular cancer	0.00352	0.00417	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00351	0.00416	CcSEcCtD
Nitisinone—Diarrhoea—Chlorambucil—testicular cancer	0.00351	0.00415	CcSEcCtD
Nitisinone—Hepatic function abnormal—Epirubicin—testicular cancer	0.0035	0.00413	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Methotrexate—testicular cancer	0.00346	0.00409	CcSEcCtD
Nitisinone—Hepatic failure—Epirubicin—testicular cancer	0.0034	0.00402	CcSEcCtD
Nitisinone—Eye pain—Epirubicin—testicular cancer	0.00338	0.004	CcSEcCtD
Nitisinone—Sepsis—Doxorubicin—testicular cancer	0.00338	0.004	CcSEcCtD
Nitisinone—Infection—Ifosfamide—testicular cancer	0.00337	0.00399	CcSEcCtD
Nitisinone—Alopecia—Etoposide—testicular cancer	0.00333	0.00394	CcSEcCtD
Nitisinone—Thrombocytopenia—Ifosfamide—testicular cancer	0.00332	0.00393	CcSEcCtD
Nitisinone—Skin disorder—Ifosfamide—testicular cancer	0.00329	0.0039	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Epirubicin—testicular cancer	0.00324	0.00383	CcSEcCtD
Nitisinone—Hepatic function abnormal—Doxorubicin—testicular cancer	0.00323	0.00383	CcSEcCtD
Nitisinone—Diarrhoea—Vinblastine—testicular cancer	0.00322	0.0038	CcSEcCtD
Nitisinone—Leukopenia—Cisplatin—testicular cancer	0.00321	0.00379	CcSEcCtD
Nitisinone—Hepatic failure—Doxorubicin—testicular cancer	0.00315	0.00372	CcSEcCtD
Nitisinone—Eye pain—Doxorubicin—testicular cancer	0.00313	0.0037	CcSEcCtD
Nitisinone—Hypoglycaemia—Epirubicin—testicular cancer	0.00313	0.0037	CcSEcCtD
Nitisinone—Convulsion—Cisplatin—testicular cancer	0.0031	0.00367	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	0.00306	0.00361	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00303	0.00358	CcSEcCtD
Nitisinone—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00303	0.00358	CcSEcCtD
Nitisinone—Somnolence—Ifosfamide—testicular cancer	0.00302	0.00357	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.003	0.00354	CcSEcCtD
Nitisinone—Headache—Vinblastine—testicular cancer	0.00294	0.00348	CcSEcCtD
Nitisinone—Leukopenia—Etoposide—testicular cancer	0.00294	0.00347	CcSEcCtD
Nitisinone—Abdominal pain—Dactinomycin—testicular cancer	0.00293	0.00346	CcSEcCtD
Nitisinone—Infection—Cisplatin—testicular cancer	0.00291	0.00344	CcSEcCtD
Nitisinone—Hypoglycaemia—Doxorubicin—testicular cancer	0.0029	0.00343	CcSEcCtD
Nitisinone—Thrombocytopenia—Cisplatin—testicular cancer	0.00286	0.00339	CcSEcCtD
Nitisinone—Convulsion—Etoposide—testicular cancer	0.00284	0.00336	CcSEcCtD
Nitisinone—Dehydration—Epirubicin—testicular cancer	0.00284	0.00336	CcSEcCtD
Nitisinone—Skin disorder—Cisplatin—testicular cancer	0.00284	0.00336	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.00283	0.00334	CcSEcCtD
Nitisinone—Pruritus—Bleomycin—testicular cancer	0.00281	0.00332	CcSEcCtD
Nitisinone—Dry skin—Epirubicin—testicular cancer	0.0028	0.00331	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00278	0.00328	CcSEcCtD
Nitisinone—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00277	0.00328	CcSEcCtD
Nitisinone—Gastritis—Epirubicin—testicular cancer	0.0027	0.0032	CcSEcCtD
Nitisinone—Abdominal pain—Ifosfamide—testicular cancer	0.00268	0.00317	CcSEcCtD
Nitisinone—Infection—Etoposide—testicular cancer	0.00266	0.00315	CcSEcCtD
Nitisinone—Dehydration—Doxorubicin—testicular cancer	0.00263	0.00311	CcSEcCtD
Nitisinone—Thrombocytopenia—Etoposide—testicular cancer	0.00262	0.0031	CcSEcCtD
Nitisinone—Skin disorder—Etoposide—testicular cancer	0.0026	0.00308	CcSEcCtD
Nitisinone—Dry skin—Doxorubicin—testicular cancer	0.00259	0.00306	CcSEcCtD
Nitisinone—Bronchitis—Epirubicin—testicular cancer	0.00254	0.003	CcSEcCtD
Nitisinone—Diarrhoea—Dactinomycin—testicular cancer	0.00253	0.003	CcSEcCtD
Nitisinone—Gastritis—Doxorubicin—testicular cancer	0.0025	0.00296	CcSEcCtD
Nitisinone—Conjunctivitis—Methotrexate—testicular cancer	0.00245	0.00289	CcSEcCtD
Nitisinone—Pruritus—Ifosfamide—testicular cancer	0.0024	0.00284	CcSEcCtD
Nitisinone—Somnolence—Etoposide—testicular cancer	0.00238	0.00282	CcSEcCtD
Nitisinone—Epistaxis—Methotrexate—testicular cancer	0.00237	0.00281	CcSEcCtD
Nitisinone—Bronchitis—Doxorubicin—testicular cancer	0.00235	0.00278	CcSEcCtD
Nitisinone—Agranulocytosis—Methotrexate—testicular cancer	0.00235	0.00278	CcSEcCtD
Nitisinone—Diarrhoea—Ifosfamide—testicular cancer	0.00232	0.00274	CcSEcCtD
Nitisinone—Conjunctivitis—Epirubicin—testicular cancer	0.00229	0.00271	CcSEcCtD
Nitisinone—Haemoglobin—Methotrexate—testicular cancer	0.00227	0.00268	CcSEcCtD
Nitisinone—Haemorrhage—Methotrexate—testicular cancer	0.00226	0.00267	CcSEcCtD
Nitisinone—Epistaxis—Epirubicin—testicular cancer	0.00222	0.00263	CcSEcCtD
Nitisinone—Agranulocytosis—Epirubicin—testicular cancer	0.0022	0.0026	CcSEcCtD
Nitisinone—Gastrointestinal pain—Etoposide—testicular cancer	0.00219	0.00259	CcSEcCtD
Nitisinone—Haemoglobin—Epirubicin—testicular cancer	0.00212	0.00251	CcSEcCtD
Nitisinone—Abdominal pain—Etoposide—testicular cancer	0.00212	0.0025	CcSEcCtD
Nitisinone—Conjunctivitis—Doxorubicin—testicular cancer	0.00212	0.0025	CcSEcCtD
Nitisinone—Haemorrhage—Epirubicin—testicular cancer	0.00211	0.0025	CcSEcCtD
Nitisinone—Eye disorder—Methotrexate—testicular cancer	0.00211	0.0025	CcSEcCtD
Nitisinone—Epistaxis—Doxorubicin—testicular cancer	0.00205	0.00243	CcSEcCtD
Nitisinone—Agranulocytosis—Doxorubicin—testicular cancer	0.00203	0.0024	CcSEcCtD
Nitisinone—Diarrhoea—Cisplatin—testicular cancer	0.002	0.00237	CcSEcCtD
Nitisinone—Alopecia—Methotrexate—testicular cancer	0.002	0.00236	CcSEcCtD
Nitisinone—Eye disorder—Epirubicin—testicular cancer	0.00198	0.00234	CcSEcCtD
Nitisinone—Haemoglobin—Doxorubicin—testicular cancer	0.00197	0.00232	CcSEcCtD
Nitisinone—Haemorrhage—Doxorubicin—testicular cancer	0.00196	0.00231	CcSEcCtD
Nitisinone—Pruritus—Etoposide—testicular cancer	0.0019	0.00224	CcSEcCtD
Nitisinone—Alopecia—Epirubicin—testicular cancer	0.00187	0.00221	CcSEcCtD
Nitisinone—Diarrhoea—Etoposide—testicular cancer	0.00183	0.00217	CcSEcCtD
Nitisinone—Eye disorder—Doxorubicin—testicular cancer	0.00183	0.00216	CcSEcCtD
Nitisinone—Tension—Epirubicin—testicular cancer	0.00181	0.00214	CcSEcCtD
Nitisinone—Nervousness—Epirubicin—testicular cancer	0.00179	0.00211	CcSEcCtD
Nitisinone—Leukopenia—Methotrexate—testicular cancer	0.00176	0.00208	CcSEcCtD
Nitisinone—Alopecia—Doxorubicin—testicular cancer	0.00173	0.00204	CcSEcCtD
Nitisinone—Convulsion—Methotrexate—testicular cancer	0.0017	0.00201	CcSEcCtD
Nitisinone—Agitation—Epirubicin—testicular cancer	0.00169	0.002	CcSEcCtD
Nitisinone—Headache—Etoposide—testicular cancer	0.00168	0.00198	CcSEcCtD
Nitisinone—Tension—Doxorubicin—testicular cancer	0.00167	0.00198	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00166	0.00197	CcSEcCtD
Nitisinone—Nervousness—Doxorubicin—testicular cancer	0.00165	0.00196	CcSEcCtD
Nitisinone—Leukopenia—Epirubicin—testicular cancer	0.00165	0.00195	CcSEcCtD
Nitisinone—Convulsion—Epirubicin—testicular cancer	0.00159	0.00189	CcSEcCtD
Nitisinone—Infection—Methotrexate—testicular cancer	0.00159	0.00189	CcSEcCtD
Nitisinone—Thrombocytopenia—Methotrexate—testicular cancer	0.00157	0.00186	CcSEcCtD
Nitisinone—Agitation—Doxorubicin—testicular cancer	0.00156	0.00185	CcSEcCtD
Nitisinone—Skin disorder—Methotrexate—testicular cancer	0.00156	0.00184	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00156	0.00184	CcSEcCtD
Nitisinone—Leukopenia—Doxorubicin—testicular cancer	0.00152	0.0018	CcSEcCtD
Nitisinone—Infection—Epirubicin—testicular cancer	0.00149	0.00176	CcSEcCtD
Nitisinone—Convulsion—Doxorubicin—testicular cancer	0.00148	0.00174	CcSEcCtD
Nitisinone—Thrombocytopenia—Epirubicin—testicular cancer	0.00147	0.00174	CcSEcCtD
Nitisinone—Skin disorder—Epirubicin—testicular cancer	0.00146	0.00173	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00144	0.0017	CcSEcCtD
Nitisinone—Somnolence—Methotrexate—testicular cancer	0.00143	0.00169	CcSEcCtD
Nitisinone—Infection—Doxorubicin—testicular cancer	0.00138	0.00163	CcSEcCtD
Nitisinone—Thrombocytopenia—Doxorubicin—testicular cancer	0.00136	0.00161	CcSEcCtD
Nitisinone—Skin disorder—Doxorubicin—testicular cancer	0.00135	0.0016	CcSEcCtD
Nitisinone—Somnolence—Epirubicin—testicular cancer	0.00134	0.00158	CcSEcCtD
Nitisinone—Gastrointestinal pain—Methotrexate—testicular cancer	0.00131	0.00155	CcSEcCtD
Nitisinone—Abdominal pain—Methotrexate—testicular cancer	0.00127	0.0015	CcSEcCtD
Nitisinone—Somnolence—Doxorubicin—testicular cancer	0.00124	0.00146	CcSEcCtD
Nitisinone—Gastrointestinal pain—Epirubicin—testicular cancer	0.00123	0.00145	CcSEcCtD
Nitisinone—Abdominal pain—Epirubicin—testicular cancer	0.00119	0.0014	CcSEcCtD
Nitisinone—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00114	0.00134	CcSEcCtD
Nitisinone—Pruritus—Methotrexate—testicular cancer	0.00114	0.00134	CcSEcCtD
Nitisinone—Abdominal pain—Doxorubicin—testicular cancer	0.0011	0.0013	CcSEcCtD
Nitisinone—Diarrhoea—Methotrexate—testicular cancer	0.0011	0.0013	CcSEcCtD
Nitisinone—Pruritus—Epirubicin—testicular cancer	0.00106	0.00126	CcSEcCtD
Nitisinone—Diarrhoea—Epirubicin—testicular cancer	0.00103	0.00122	CcSEcCtD
Nitisinone—Headache—Methotrexate—testicular cancer	0.00101	0.00119	CcSEcCtD
Nitisinone—Pruritus—Doxorubicin—testicular cancer	0.000983	0.00116	CcSEcCtD
Nitisinone—Diarrhoea—Doxorubicin—testicular cancer	0.000951	0.00112	CcSEcCtD
Nitisinone—Headache—Epirubicin—testicular cancer	0.000941	0.00111	CcSEcCtD
Nitisinone—Headache—Doxorubicin—testicular cancer	0.00087	0.00103	CcSEcCtD
